tradingkey.logo
tradingkey.logo
Search

Progyny Inc

PGNY
Add to Watchlist
29.450USD
+0.620+2.15%
Close 07/01, 16:00ETQuotes delayed by 15 min
2.31BMarket Cap
36.51P/E TTM
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+2.15%

5 Days

+10.59%

1 Month

+15.22%

6 Months

+14.68%

Year to Date

+14.68%

1 Year

+33.86%

Key Figures
29.250Open
30.100High
1.50MVolume
36.51P/E TTM
18.84P/E Dynamic
--Dividend TTM
1.91%Turnover Ratio
28.830Prev. Close
29.084Low
36.46MTurnover
42.42P/E Static
5.25P/B
0.00%Div Yield TTM
9.48%ROA
28.75052wk High
1.29Volume Ratio
54.34MNet Profit
78.27MShares
0.8065EPS TTM
1.02Beta
14.93%ROE
16.10052wk Low
3.52%Amplitude
25.29%Gross Margin
2.31BMarket Cap
5.42Reward/Risk
2.73%Risk Rate

TradingKey Stock Score of Progyny Inc

Currency: USD Updated: 2026-06-30

Key Insights

Progyny Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 12 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Progyny Inc's Score

Industry at a Glance

Industry Ranking
12 / 76
Overall Ranking
67 / 4569
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Progyny Inc Highlights

StrengthsRisks
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 18.38% year-on-year.
Fairly Valued
The company’s latest PE is 35.74, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 88.51M shares, decreasing 26.54% quarter-over-quarter.
Held by John Hussman
Star Investor John Hussman holds 140.11K shares of this stock.

Analyst Rating

Based on 11 analysts
Buy
Current Rating
30.000
Target Price
+4.06%
Upside Space

Progyny Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Progyny Inc Info

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Ticker SymbolPGNY
CompanyProgyny Inc
CEOAnevski (Peter)
Websitehttps://www.progyny.com/

FAQs

What is the current price of Progyny Inc (PGNY)?

The current price of Progyny Inc (PGNY) is 28.83.

What is the symbol of Progyny Inc?

The ticker symbol of Progyny Inc is PGNY.

What is the 52-week high of Progyny Inc?

The 52-week high of Progyny Inc is 28.75.

What is the 52-week low of Progyny Inc?

The 52-week low of Progyny Inc is 16.10.

What is the market capitalization of Progyny Inc?

The market capitalization of Progyny Inc is 2.26B.

Is Progyny Inc (PGNY) currently rated as Buy, Hold, or Sell?

According to analysts, Progyny Inc (PGNY) has an overall rating of Buy, with a price target of 30.00.

What is the Earnings Per Share (EPS TTM) of Progyny Inc (PGNY)?

The Earnings Per Share (EPS TTM) of Progyny Inc (PGNY) is 0.68.